AMPA receptor positive allosteric modulator

From WikiMD.com Medical Encyclopedia

AMPA receptor positive allosteric modulator

Chemical structure of CX-516
Chemical structure of Tulrampator

An AMPA receptor positive allosteric modulator is a type of compound that enhances the activity of the AMPA receptor, a subtype of the ionotropic glutamate receptors in the central nervous system. These modulators bind to the receptor at a site distinct from the glutamate binding site, leading to an increase in the receptor's response to glutamate.

Mechanism of Action[edit | edit source]

AMPA receptor positive allosteric modulators work by binding to the allosteric site on the AMPA receptor. This binding induces a conformational change in the receptor, which increases its affinity for glutamate and/or prolongs the open state of the ion channel. As a result, there is an increase in the flow of sodium ions (Na_) and calcium ions (Ca__) into the neuron, leading to enhanced synaptic transmission and neuroplasticity.

Pharmacological Effects[edit | edit source]

The primary effect of AMPA receptor positive allosteric modulators is the potentiation of excitatory synaptic transmission. This can lead to improved cognitive function, enhanced memory, and increased alertness. These compounds are being investigated for their potential therapeutic effects in conditions such as Alzheimer's disease, schizophrenia, and depression.

Examples[edit | edit source]

Several compounds have been identified as AMPA receptor positive allosteric modulators, including:

  • CX-516: Also known as Ampalex, CX-516 is one of the first AMPA receptor modulators to be studied for its cognitive-enhancing effects.
  • Tulrampator: A more recent compound, Tulrampator has shown promise in preclinical studies for its potential to improve cognitive function.

Research and Development[edit | edit source]

Research into AMPA receptor positive allosteric modulators is ongoing, with a focus on developing compounds with improved efficacy and safety profiles. Challenges include minimizing potential side effects such as excitotoxicity and seizures, which can result from excessive activation of glutamate receptors.

Related pages[edit | edit source]

Gallery[edit | edit source]

  • Chemical structure of CX-516

  • Chemical structure of Tulrampator

AMPA_receptor_positive_allosteric_modulator[edit | edit source]

  • CX-516 2D skeletal structure

  • Tulrampator skeletal structure

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.com/w/index.php?title=AMPA_receptor_positive_allosteric_modulator&oldid=6311842"

Contributors: Prab R. Tumpati, MD